Q2 2020 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q2 FY '20 Earnings Conference Call. We have with us on the call today Mr. Sanjay Gupta, Executive Director, International business; Mr. Sudhir Menon, Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India Business.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Sanjay Gupta. Thank you and over to you, sir.
Thank you, Raymond. Good evening, everyone, and welcome to our Q2 FY '20 earnings call. Let's start with the financial results. Q2 revenues were INR 2,005 crores, up by 6% on a year-on-year basis. EBITDA was INR 573 crores, up by 20% on a year-on-year basis, and EBITDA margins were at 28.6%, an improvement of 1% on a Q-on-Q basis and 3.3% on a year-on-year basis.
I would now like to take you through some trends in our key markets. India contributed 45% of our total
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |